These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 598687)

  • 21. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction.
    Halter JB; Beard JC; Porte D
    Am J Physiol; 1984 Jul; 247(1 Pt 1):E47-52. PubMed ID: 6377920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic norepinephrine infusion and insulin and glucagon secretion in the dog.
    Raum WJ; Swerdloff RS; Garner D; Laks H; Laks MM
    Am J Physiol; 1984 Mar; 246(3 Pt 1):E232-6. PubMed ID: 6367484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose metabolism and plasma insulin level during epinephrine infusion in the dog.
    Altszuler N; Steele R; Rathgeb I; De Bodo RC
    Am J Physiol; 1967 Mar; 212(3):677-82. PubMed ID: 6020543
    [No Abstract]   [Full Text] [Related]  

  • 24. The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats.
    Matsunaga H; Iguchi A; Yatomi A; Uemura K; Miura H; Gotoh M; Mano T; Sakamoto N
    Endocrinology; 1989 Mar; 124(3):1259-64. PubMed ID: 2563682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon and insulin secretion and their biological activities in hypothermic rats.
    Helman A; Gilbert M; Pfister-Lemaire N; Réach G; Assan R
    Endocrinology; 1984 Nov; 115(5):1722-8. PubMed ID: 6436006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic insulin and glucagon extraction after their augmented secretion in dogs.
    Röjdmark S; Bloom G; Chou MC; Jaspan JB; Field JB
    Am J Physiol; 1978 Jul; 235(1):E88-96. PubMed ID: 677314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of glucose from the liver of fetal and postnatal sheep by portal vein infusion of catecholamines or glucagon.
    Apatu RS; Barnes RJ
    J Physiol; 1991 May; 436():449-68. PubMed ID: 2061840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of insulin secretion in myotonic dystrophy.
    Huff TA; Lebovitz HE
    J Clin Endocrinol Metab; 1968 Jul; 28(7):992-8. PubMed ID: 4873207
    [No Abstract]   [Full Text] [Related]  

  • 30. Involvement of nitric oxide in neuroglycopenia-induced insulin and glucagon secretion in the mouse.
    Ahrén B; Karlsson S; Scheurink AJ; Steffens AB
    Eur J Pharmacol; 1995 Jun; 280(1):27-35. PubMed ID: 7498251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo stimulation of pancreatic hormone secretion by norepinephrine infusion in the dog.
    Ribes G; Trimble ER; Blayac JP; Wollheim CB; Loubatières-Mariani MM
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E339-43. PubMed ID: 6144271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
    Beard JC; Weinberg C; Pfeifer MA; Best JD; Halter JB; Porte D
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1271-7. PubMed ID: 6841561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined infusion of epinephrine and norepinephrine during moderate exercise reproduces the glucoregulatory response of intense exercise.
    Kreisman SH; Halter JB; Vranic M; Marliss EB
    Diabetes; 2003 Jun; 52(6):1347-54. PubMed ID: 12765943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of cortisol in the metabolic response to stress hormone infusion in the conscious dog.
    Fujiwara T; Cherrington AD; Neal DN; McGuinness OP
    Metabolism; 1996 May; 45(5):571-8. PubMed ID: 8622599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glucagon and epinephrine on serum insulin and insulin secretion in dogs.
    Campbell J; Rastogi KS
    Endocrinology; 1966 Oct; 79(4):830-5. PubMed ID: 5957197
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of acute glucagon removal on the metabolic response to stress hormone infusion in the conscious dog.
    McGuinness OP; Murrell S; Moran C; Bracy D; Cherrington AD
    Metabolism; 1994 Oct; 43(10):1310-7. PubMed ID: 7934986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of plasma immunoreactive glucagon in obese hyperglycaemic (ob/ob) mice.
    Flatt PR; Bailey CJ; Buchanan KD
    J Endocrinol; 1982 Nov; 95(2):215-27. PubMed ID: 6757362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
    Leahy JL; Weir GC
    Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.